News articles

News article list

• First-ever NHS treatment approved for advanced Hodgkin lymphoma

  New combination therapy offers hope to 800 people annually with late-stage blood cancer.

• Changes approved to the routing criteria for highly specialised technologies

  At its meeting on 19 March our Board approved changes to the criteria we use to decide which treatments should be evaluated, to ensure more consistent, predictable and transparent decisions.

• Annual BMI checks recommended for adults with long-term conditions

  We've published a draft quality standard calling for yearly BMI and waist-to-height measurements to help prevent weight-related complications.

• First licensed treatment for ultra-rare immune disorder recommended

  Leniolisib is the first ever treatment for activated phosphoinositide 3-kinase delta syndrome (APDS) licensed for use in the NHS in England.

• First daily pill for endometriosis approved for NHS use

  Today we've recommended the first long-term daily pill to treat endometriosis that could transform how this painful condition is managed.

• Second consultation launched on NHS funding for Alzheimer's treatments

  Cost and evidence gaps remain barriers to approving funding in the NHS for donanemab and lecanemab.